Skip to main content

Table 4 Comparison of bacilli negative conversion rates of pulmonary Mycobacterium avium complex patients between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Group Follow-up period (months)
Start of treatment 1 3 6 12
Control 0/57 (0 %) 28/57 (49 %) 41/52 (79 %) 39/48 (81 %) 32/42 (76 %)
LVFX 0/18 (0 %) 5/18 (28 %) *3/8 (38 %) 4/6 (67 %) 2/3 (67 %)
  1. If the results of both the smear and the culture examination were negative, the patients were classed as “bacilli negative conversion.” *A P-value of less than 0.05 was considered statistically significant